Right to Try Clarification Act

Summary

Right to Try Clarification Act This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 20 July 2022

   Introduced

   Read twice and referred to the Committee on the Judiciary.

   Source: IntroReferral

2. 20 July 2022

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 20 July 2022 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 20 July 2022

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 20 July 2022

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 20 July 2022

  Open at official source

Sponsors

• Sen. Booker, Cory A. [D-NJ] · D · Sponsor
• Rand Paul · R · Sponsor
• · ssju00 · Standing

Related records

• related to ← Right to Try Clarification Act